Keurig Dr Pepper Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +45

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Keurig Dr ...

AI-generated analysis

πŸ“ˆ JPMorgan Chase & Co. increased its price target for Keurig Dr Pepper from $33.00 to $38.00, projecting a potential upside of 28.03%.

🏦 Citigroup and UBS Group also raised their price objectives to $37.00 and $38.00 respectively, reinforcing the 'buy' sentiment among major equities analysts.

βš–οΈ BNP Paribas Exane downgraded the stock to 'neutral' with a $28.00 target, while Zacks Research lowered its rating from 'strong-buy' to 'hold'.

πŸ’° The company reported quarterly earnings of $0.39 per share, surpassing analyst expectations of $0.37.

πŸ“‰ Revenue for the quarter came in at $3.98 billion, significantly below the consensus estimate of $7.23 billion.

πŸ“ˆ Year-over-year revenue growth remained positive at 9.4%, indicating underlying business expansion despite the quarterly miss.

🏭 Keurig Dr Pepper maintained strong profitability with a 10.51% return on equity and a 10.81% net margin.

πŸ“Š Institutional ownership is heavily concentrated, with hedge funds and other institutions holding 93.99% of the company's stock.

πŸš€ Empowered Funds LLC increased its stake by 248%, now owning shares valued at approximately $2.39 million.

πŸ”Ό Jump Financial LLC boosted its position by 253.6%, acquiring an additional 54,571 shares in the second quarter.

πŸ“ˆ NewEdge Advisors grew its stake by 30.6% in the first quarter, adding 3,627 shares to its portfolio.

πŸ†• Woodline Partners LP raised its position by 49.2%, increasing its holdings to over 100,000 shares valued at $3.45 million.

Bullish Signals
  • JPMorgan Chase & Co. raised its price target from $33.00 to $38.00, suggesting a 28.03% upside potential from the current price.
  • Citigroup lifted its price objective to $37.00 and maintained a 'buy' rating, while UBS Group also raised its target to $38.00 with a 'buy' rating.
  • The company beat quarterly earnings expectations by reporting $0.39 EPS against a consensus of $0.37.
  • Revenue grew 9.4% year-over-year to $3.98 billion, demonstrating continued top-line expansion despite the absolute miss.
  • Profitability remains strong with a 10.51% return on equity and a 10.81% net margin.
  • Empowered Funds LLC significantly increased its stake by 248%, reflecting strong institutional confidence in the business.
  • Jump Financial LLC boosted its position by 253.6%, adding over 54,000 shares to its portfolio in the second quarter.
  • NewEdge Advisors grew its holdings by 30.6% in the first quarter, increasing its total stake value to $530,000.
Risk Factors
  • BNP Paribas Exane downgraded the stock from 'outperform' to 'neutral' with a lower price target of $28.00.
  • Zacks Research downgraded the stock from a 'strong-buy' rating to a 'hold' rating in May 2026.
  • Quarterly revenue of $3.98 billion missed the analyst consensus estimate of $7.23 billion significantly.
Full Analysis
JPMorgan Chase & Co. raised its price target for Keurig Dr Pepper (KDP) from $33.00 to $38.00, citing strong potential for price appreciation while maintaining an 'overweight' rating. This move aligns with recent bullish actions from other major institutions, including Citigroup and UBS Group, which also lifted their price targets or ratings in late July 2026. Conversely, BNP Paribas Exane downgraded the stock to 'neutral' with a $28.00 target, and Zacks Research recently shifted its rating from 'strong-buy' to 'hold', resulting in a consensus 'Hold' rating across eight buy and nine hold analysts. Keurig Dr Pepper reported quarterly earnings on April 23rd, delivering $0.39 per share which beat the consensus estimate of $0.37. However, revenue figures showed a significant miss against expectations, with actuals at $3.98 billion compared to a consensus forecast of $7.23 billion. Despite the revenue shortfall, the company demonstrated operational resilience with a 9.4% year-over-year revenue increase and maintained healthy profitability metrics, including a 10.51% return on equity and a 10.81% net margin. Institutional investor sentiment remains robust as several hedge funds significantly increased their stakes in the company during the first and second quarters of 2026. Notable increases include Empowered Funds LLC, which grew its position by 248%, and Jump Financial LLC, which boosted holdings by over 250%. NewEdge Advisors and Woodline Partners also raised their positions substantially, while Sivia Capital Partners initiated a new stake. Collectively, hedge funds and institutional investors now control approximately 93.99% of the outstanding shares.